Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4269]

U.S. FDA approves olaparib in BRCA-mutated metastatic breast cancer

U.S. FDA approves olaparib in BRCA-mutated metastatic breast cancer

NIH researchers report first 3-D structure of DHHC enzymes

NIH researchers report first 3-D structure of DHHC enzymes

Survival for young breast cancer patients is the same whether or not they carry a BRCA mutation

Survival for young breast cancer patients is the same whether or not they carry a BRCA mutation

Oestrogen-mimicking compounds in foods may reduce effectiveness of breast cancer treatment

Oestrogen-mimicking compounds in foods may reduce effectiveness of breast cancer treatment

Researchers find protein that mediates formation of HER2-driven breast cancer

Researchers find protein that mediates formation of HER2-driven breast cancer

Targeting breast cancer through precision medicine

Targeting breast cancer through precision medicine

New treatments, screening methods dramatically reduce US breast cancer deaths

New treatments, screening methods dramatically reduce US breast cancer deaths

Scientists identify breast cancer patients who may develop incurable secondary cancers

Scientists identify breast cancer patients who may develop incurable secondary cancers

Gene test to predict breast cancer recurrence less cost effective in real world practice

Gene test to predict breast cancer recurrence less cost effective in real world practice

FDA issues Breakthrough Therapy designation for ribociclib for premenopausal women with HR /HER2- advanced breast cancer

FDA issues Breakthrough Therapy designation for ribociclib for premenopausal women with HR /HER2- advanced breast...

More from ecancer